| scholarly article | Q13442814 |
| P2093 | author name string | Edda Fiebiger | |
| Timo Rath | |||
| Masaru Yoshida | |||
| Richard S Blumberg | |||
| Kanna Kobayashi | |||
| Timothy T Kuo | |||
| Wayne I Lencer | |||
| Kristi Baker | |||
| Derry Roopenian | |||
| Shuo-Wang Qiao | |||
| P2860 | cites work | A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus | Q24337337 |
| Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin | Q24645189 | ||
| The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan | Q24673691 | ||
| Redistribution of the sheep neonatal Fc receptor in the mammary gland around the time of parturition in ewes and its localization in the small intestine of neonatal lambs | Q24682712 | ||
| Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity | Q27489852 | ||
| Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding | Q27631600 | ||
| X-ray Crystal Structures of Monomeric and Dimeric Peptide Inhibitors in Complex with the Human Neonatal Fc Receptor, FcRn | Q27662922 | ||
| The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans | Q28208533 | ||
| Neonatal Fc receptor and IgG-based therapeutics | Q28252134 | ||
| An Fc receptor structurally related to MHC class I antigens | Q28569860 | ||
| Receptor-mediated transport of IgG | Q30442369 | ||
| The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity | Q30485266 | ||
| Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn | Q33319667 | ||
| Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. | Q33343985 | ||
| Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. | Q33346093 | ||
| Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia | Q33348131 | ||
| Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. | Q33902330 | ||
| Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies | Q34102657 | ||
| Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor | Q34244234 | ||
| Neonatal Fc receptor: from immunity to therapeutics | Q34268801 | ||
| Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. | Q34294972 | ||
| Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. | Q34402831 | ||
| Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection | Q34693822 | ||
| Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria | Q34768249 | ||
| Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells | Q35049100 | ||
| Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies | Q35214746 | ||
| Efficient mucosal vaccination mediated by the neonatal Fc receptor. | Q35399345 | ||
| Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. | Q35546930 | ||
| Mechanisms of MHC class I-restricted antigen processing and cross-presentation | Q36266466 | ||
| Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1. | Q52576953 | ||
| The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. | Q53828120 | ||
| A Theoretical Model of γ-Globulin Catabolism | Q59081837 | ||
| Isolation and characterization of an Fc receptor from neonatal rat small intestine | Q70089834 | ||
| Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc | Q70672540 | ||
| Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice | Q71012001 | ||
| Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor | Q72715944 | ||
| Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn | Q73027779 | ||
| Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn | Q73046074 | ||
| Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1 | Q73082065 | ||
| The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs | Q73149177 | ||
| Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans | Q78960971 | ||
| Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade | Q80088102 | ||
| Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung | Q36370858 | ||
| Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway | Q36448851 | ||
| Podocytes use FcRn to clear IgG from the glomerular basement membrane | Q36458931 | ||
| Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway | Q36602166 | ||
| Mouse MHC class I-like Fc receptor encoded outside the MHC. | Q36673236 | ||
| Dependence of antibody-mediated presentation of antigen on FcRn | Q36756942 | ||
| An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta | Q36814851 | ||
| FcRn: the neonatal Fc receptor comes of age. | Q36912134 | ||
| Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice | Q37115251 | ||
| Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. | Q37220781 | ||
| Molecular engineering and design of therapeutic antibodies | Q37227301 | ||
| Antigen presentation in celiac disease. | Q37430981 | ||
| An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice. | Q37454723 | ||
| Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. | Q37502056 | ||
| The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor | Q37590654 | ||
| Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice | Q37661162 | ||
| Intracellular mechanisms of antigen cross presentation in dendritic cells | Q37695674 | ||
| The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease | Q37698818 | ||
| Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases | Q39632316 | ||
| Enhanced antibody half-life improves in vivo activity | Q40045495 | ||
| Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism | Q40078990 | ||
| Apical to basolateral transcytosis and apical recycling of immunoglobulin G in trophoblast-derived BeWo cells: effects of low temperature, nocodazole, and cytochalasin D. | Q40778738 | ||
| Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells | Q40826883 | ||
| Cloning and characterization of the bovine MHC class I-like Fc receptor | Q40902406 | ||
| Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand | Q41680426 | ||
| The transmission of immune globulins from the mother to the foetal and newborn young | Q43643314 | ||
| Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. | Q45023089 | ||
| The class I major histocompatibility complex related Fc receptor shows pH-dependent stability differences correlating with immunoglobulin binding and release | Q46077540 | ||
| High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. | Q46117208 | ||
| Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. | Q46478074 | ||
| Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine | Q46546664 | ||
| Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. | Q47365627 | ||
| The chicken yolk sac IgY receptor, a functional equivalent of the mammalian MHC-related Fc receptor, is a phospholipase A2 receptor homolog | Q47607389 | ||
| Sequence and expression of the FcRn in the porcine mammary gland | Q48259584 | ||
| Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. | Q51110501 | ||
| Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). | Q51174776 | ||
| An engineered human IgG1 antibody with longer serum half-life. | Q51301844 | ||
| Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. | Q51348965 | ||
| Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway. | Q51350436 | ||
| Albumin binding to FcRn: distinct from the FcRn-IgG interaction. | Q51808620 | ||
| Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis. | Q51818158 | ||
| Expression of the Fc receptor in the mammary gland during lactation in the marsupial Trichosurus vulpecula (brushtail possum). | Q52144468 | ||
| P304 | page(s) | S9-17 | |
| P577 | publication date | 2012-09-05 | |
| P1433 | published in | Journal of Clinical Immunology | Q6294961 |
| P1476 | title | The immunologic functions of the neonatal Fc receptor for IgG | |
| P478 | volume | 33 Suppl 1 |
| Q38292087 | Albumin and its application in drug delivery |
| Q90523456 | Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? |
| Q40237489 | An investigation into the effects of maternal supplementation with excess iodine on the mechanisms and impacts of reduced IgG absorption in the lamb postpartum. |
| Q91808144 | Antibody Structure and Function: The Basis for Engineering Therapeutics |
| Q37689507 | Antigen cross-presentation of immune complexes |
| Q38217623 | Assessment of the metabolism of therapeutic proteins and antibodies |
| Q38257496 | CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity |
| Q37138255 | Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori). |
| Q37079801 | Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model |
| Q37138959 | Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor |
| Q35545292 | Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge |
| Q48294090 | Detection of ovomucoid-specific low-affinity IgE in infants and its relationship to eczema. |
| Q40007308 | Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc. |
| Q36214076 | Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn |
| Q34389202 | Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy |
| Q34937851 | Expression and function of the lipocalin-2 (24p3/NGAL) receptor in rodent and human intestinal epithelia |
| Q47844351 | FCRLA-A Resident Endoplasmic Reticulum Protein that Associates with Multiple Immunoglobulin Isotypes in B Lineage Cells. |
| Q35670904 | FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin. |
| Q86332982 | Food allergens are transferred intact across the rat blood-placental barrier in vivo |
| Q45875104 | From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance |
| Q47764097 | Hepatic function of FcRn revealed: Implications for overcoming drug-mediated hepatotoxicity. |
| Q47593242 | IgG Fc engineering to modulate antibody effector functions |
| Q26745000 | Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor |
| Q36131665 | Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors |
| Q92372570 | Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650 |
| Q42428917 | Interspecies pharmacokinetic modeling of subcutaneous absorption of rituximab in mice and rats |
| Q37720658 | Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes |
| Q90147338 | Maternal alloimmune IgG causes anti-glomerular basement membrane disease in perinatal transgenic mice that express human laminin α5 |
| Q90364822 | Mouse fetal intestinal organoids: new model to study epithelial maturation from suckling to weaning |
| Q35866472 | Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants |
| Q51740195 | Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells. |
| Q90382714 | Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas |
| Q26738728 | Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues |
| Q93128162 | Passive immune transfer in puppies |
| Q92762054 | Plant-derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells |
| Q38090391 | Progress toward inducing immunologic tolerance to factor VIII. |
| Q38593866 | Protective role of mouse IgG1 in cryoglobulinaemia; insights from an animal model and relevance to human pathology. |
| Q27321626 | Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice |
| Q45882083 | Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein |
| Q34818194 | Regulation of immune responses by the neonatal fc receptor and its therapeutic implications |
| Q35368495 | Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model |
| Q28080589 | Targeting FcRn for the modulation of antibody dynamics |
| Q35754853 | The Arp2/3 complex has essential roles in vesicle trafficking and transcytosis in the mammalian small intestine |
| Q50130439 | The Human Penis Is a Genuine Immunological Effector Site |
| Q93369828 | The Potential of Exosomes From Cow Milk for Oral Delivery |
| Q31162899 | The first thousand days - intestinal microbiology of early life: establishing a symbiosis. |
| Q28257521 | The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy |
| Q33997395 | The role of Fc receptors in HIV infection and vaccine efficacy. |
| Q93052070 | Tolerating Factor VIII: Recent Progress |
| Q88194388 | Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia |
| Q89620890 | Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn Expression via Nucleocapsid Protein and Secretion of TGF-β in Porcine Intestinal Epithelial Cells |
| Q91871894 | Transnuclear mice reveal Peyer's patch iNKT cells that regulate B-cell class switching to IgG1 |
| Q47436060 | Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-D-glucosaminidase in glomerulonephritis |
Search more.